The company has been listed in China Industry News as a new "dark horse" in medical technology, breaking the monopoly of Western technology and filling the domestic gap
The company has been listed in China Industry News as a new "dark horse" in medical technology, breaking the monopoly of Western technology and filling the domestic gap
September 24, 2024
China Industry News is an authoritative mainstream media in the field of industry and information technology in China, serving managers of industrial enterprises and industries.
On September 23rd, China Industry News reported on Medpurest's significant breakthrough in the field of high-end medical devices. As a high-tech enterprise focused on innovative medical solutions, Medpurest has not only successfully broken the long-standing technological monopoly of Western countries, but also filled the gap in China's absorbable hemostatic materials field, demonstrating the company's strong strength as a new "dark horse" in the medical technology field.
Technological innovation leads industry transformation:
Since its establishment, the company has been committed to promoting technological innovation and development in China's medical device industry. The product that caught the attention of China Industry News this time - absorbable hemostatic microspheres, is the result of our company's years of scientific research and development. This material can quickly control bleeding points during surgery and naturally degrade into substances acceptable to the human body over time, greatly improving the quality and speed of postoperative recovery for patients.
Its emergence not only marks another milestone in the localization of imported products, but also provides clinical doctors with safer and more reliable treatment options.
The role transition from catching up to leading
For a long time, it has been common for China to rely on foreign imports for certain cutting-edge medical equipment and consumables. But with the rise of local companies represented by Medpurest, this situation is undergoing fundamental changes.
By continuously increasing research and development investment, introducing international advanced technology and management experience, Medpurest has grown into one of the important forces that can compete with international giants. Especially in the research and development of medical hemostatic products and high-end medical cleaning products, the success has shown the world the enormous potential and development prospects of Chinese enterprises in this field.
In the future, Medpurest will continue to adhere to the innovation driven development strategy, adhere to the path of high-quality development, and strive to become a globally leading medical technology innovation enterprise.